30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Scopa James Paul

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -68%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Scopa James Paul's trades of Adverum Biotechnologies Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-09 2024-02-07
B Purchase
69,056 +45.4%
275.48
US$4,531,501 		69,056 +45.4% 275.48 US$4,531,501
2023-03-21 2023-03-17
S Sale
46,132 -14.7%
49.64
US$2,725,596 		46,132 -14.7% 49.64 US$2,725,596
2021-11-17 2021-11-15
S Sale
94,410 +45.2%
227.65
US$1,201,240 		94,410 +45.2% 227.65 US$1,201,240
2020-02-14 2020-02-14
B Purchase
10,000 +50.0%
13.75
US$137,500 		10,000 +50.0% 13.75 US$137,500
2019-05-06 2019-05-06
B Purchase
20,000 +inf%
6.71
US$134,200 		20,000 +inf% 6.71 US$134,200